Join our community of smart investors

Serco surmounts loss of Covid contracts

The outsourcer boosts guidance again after proving its resilience
August 4, 2022
  • Revenue remains stable 
  • Net debt falls 

Serco (SRP) did very well out of the pandemic. Test & Trace contracts accelerated its sales growth, and the group became governments’ go-to outsourcer during the crisis.

This is subscriber only content
Start your trial to keep reading
PRINT AND DIGITAL trial

Get 12 weeks for £12
  • Essential access to the website and app
  • Magazine delivered every week
  • Investment ideas, tools and analysis
Have an account? Sign in